欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
SE/H/2245/001
药品名称
Sunitinib Bluefish
活性成分
SUNITINIB 12.5 mg
剂型
Capsule, hard
上市许可持有人
Bluefish Pharmaceuticals AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Germany (DE)
Sunitinib Bluefish 12,5 mg Hartkapseln
Ireland (IE)
Austria (AT)
Portugal (PT)
Poland (PL)
Sunitinib Bluefish
许可日期
2023/01/18
最近更新日期
2024/07/08
药物ATC编码
L01EX01 sunitinib
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
PubAR
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20220204000116
Date of last change:2024/09/06
PubAR Summary
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20220204000116_2
Date of last change:2024/09/06
Final SPC
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_medProdName_sunitinib_20bluefish_activeTab_1
Date of last change:2024/09/06
Final PL
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_medProdName_sunitinib_20bluefish_activeTab_1_2
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase